Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,741 to 1,760 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biology, evolution, and history of antigen processing and presentation: Immunogenetics special issue 2019. | Immunogenetics | 2019 | 30706092 | PubTator, text mining | PubMed |
| Hypomethylation of STAT1 and HLA-DRB1 is associated with type-I interferon-dependent HLA-DRB1 expression in lupus CD8+ T cells. | Ann Rheum Dis | 2019 | 30674474 | PubTator, text mining | PubMed |
| RAGE is a Critical Mediator of Pulmonary Oxidative Stress, Alveolar Macrophage Activation and Emphysema in Response to Cigarette Smoke. | Sci Rep | 2019 | 30659203 | PubTator, text mining | PubMed |
| The blood transcriptome of childhood malaria. | EBioMedicine | 2019 | 30638864 | PubTator, text mining | PubMed |
| Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity. | Sci Immunol | 2019 | 30635355 | PubTator, text mining | PubMed |
| Human leukocyte antigen class II expression is a good prognostic factor in adult T-cell leukemia/lymphoma. | Haematologica | 2019 | 30630986 | PubTator, text mining | PubMed |
| Interferon-gamma production in Lyme arthritis synovial tissue promotes differentiation of fibroblast-like synoviocytes into immune effector cells. | Cell Microbiol | 2019 | 30550623 | PubTator, text mining | PubMed |
| Biallelic CCM3 mutations cause a clonogenic survival advantage and endothelial cell stiffening. | J Cell Mol Med | 2019 | 30549232 | PubTator, text mining | PubMed |
| Immunoprofiles of colorectal cancer from Lynch syndrome. | Oncoimmunology | 2019 | 30546958 | PubTator, text mining | PubMed |
| Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA. | Am J Surg Pathol | 2019 | 30540571 | PubTator, text mining | PubMed |
| Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis. | Cancer Treat Res | 2019 | 30523620 | PubTator, text mining | PubMed |
| Biological Consequences of MHC-II Expression by Tumor Cells in Cancer. | Clin Cancer Res | 2019 | 30463850 | PubTator, text mining | PubMed |
| Downregulation of NLRP2 inhibits HUVEC viability by inhibiting the MAPK signaling pathway. | Mol Med Rep | 2019 | 30431084 | PubTator, text mining | PubMed |
| Therapeutic targeting of transcriptional cyclin-dependent kinases. | Transcription | 2019 | 30409083 | PubTator, text mining | PubMed |
Mutational activation of the epidermal growth factor receptor down-regulates major histocompatibility complex class I expression via the extracellular signal-regulated kinase in non-small cell lung cancer. | Cancer Sci | 2019 | 30390416 | PubTator, text mining | PubMed |
| TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cells. | Haematologica | 2019 | 30381301 | PubTator, text mining | PubMed |
| The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth. | Cancer Immunol Immunother | 2019 | 30334128 | PubTator, text mining | PubMed |
| The MHC in the era of next-generation sequencing: Implications for bridging structure with function. | Hum Immunol | 2019 | 30321633 | PubTator, text mining | PubMed |
| Bisphenol A exposure alters placentation and causes preeclampsia-like features in pregnant mice involved in reprogramming of DNA methylation of WNT2. | FASEB J | 2019 | 30303745 | PubTator, text mining | PubMed |
| Robust interferon signature and suppressed tissue repair gene expression in synovial tissue from patients with postinfectious, Borrelia burgdorferi-induced Lyme arthritis. | Cell Microbiol | 2019 | 30218476 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=88